0000950170-24-010968.txt : 20240202
0000950170-24-010968.hdr.sgml : 20240202
20240202212559
ACCESSION NUMBER: 0000950170-24-010968
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vavricka John
CENTRAL INDEX KEY: 0001829630
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 24593700
MAIL ADDRESS:
STREET 1: C/O ATEA PHARMACEUTICALS, INC.
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
ownership.xml
4
X0508
4
2024-01-31
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001829630
Vavricka John
225 FRANKLIN STREET
SUITE 2100
BOSTON
MA
02110
false
true
false
false
Chief Commercial Officer
false
Common Stock
2024-01-31
4
M
false
33334
A
33334
D
Common Stock
2024-02-01
4
S
false
11819
3.8430
D
21515
D
Common Stock
82508
I
Held by John Vavricka as the Trustee of the John F. Vavricka Deed of Trust
Restricted Stock Units
2024-01-31
4
M
false
33334
0
D
Common Stock
33334
66666
D
Stock Option (Right to Buy)
4.16
2024-01-31
4
A
false
132800
0
A
2034-01-30
Common Stock
132800
132800
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 25, 2022.
The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.
The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.
/s/ Andrea Corcoran, as Attorney-in-Fact for John Vavricka
2024-02-02